CYTK insider gifts 2,000 shares; holdings now 356,108 direct
Cytokinetics (CYTK) reported an insider transaction on a Form 4.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Cytokinetics (CYTK) reported an insider transaction on a Form 4. The company’s President & CEO and Director reported a bona fide gift (Code G) of 2,000 shares of common stock on 11/05/2025 at a price of $0.
Following the transaction, the reporting person beneficially owns 356,108 shares directly, plus 2,083 shares held indirectly by The Bridget Blum 2003 Irrevocable Trust and 2,083 shares held indirectly by The Brittany Blum 2003 Irrevocable Trust.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Common Stock | 2,000 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (2)
- F1. Shares held by The Bridget Blum 2003 Irrevocable Trust.
- F2. Shares held by The Brittany Blum 2003 Irrevocable Trust.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did CYTK’s insider report on Form 4?
Who is the reporting person in the CYTK Form 4?
What indirect CYTK holdings are disclosed?
What does transaction code G mean on Form 4?
What is the CYTK ticker and issuer name?
AI-generated analysis. How Rhea-AI works. Not financial advice.